Refine
Has Fulltext
- yes (25)
Is part of the Bibliography
- yes (25)
Year of publication
Document Type
- Journal article (23)
- Preprint (2)
Language
- English (25)
Keywords
- glycine receptor (7)
- hyperekplexia (3)
- startle disease (3)
- Cys-loop receptor (2)
- autoantibodies (2)
- binding (2)
- cortical neurons (2)
- melt electrowriting (2)
- neurofascin (2)
- neurology (2)
- passive transfer (2)
- synaptic inhibition (2)
- 3D cell cultures (1)
- 3D cultures (1)
- 3D electrophysiology (1)
- 3D model systems (1)
- 3D neuronal networks (1)
- 7,8-dihydroxyflavone (7,8-DHF) (1)
- Asc-1 transporter (1)
- CIDP (1)
- Ca\(^{2+}\)-Imaging (1)
- GABA-A receptor (1)
- GABA\(_{A}\) (1)
- GABA\(_{A}\) receptor (1)
- GlyR receptors (1)
- GlyRs (1)
- Guillain-Barre-Syndrome (1)
- IgG4 (1)
- NMDAR (1)
- PDXP inhibitors (1)
- activation (1)
- adsorption (1)
- allosteric modulation (1)
- anti-contactin-1 (1)
- antibodies (1)
- anxiety (1)
- astrocytes (1)
- autoantibody (1)
- autoantibody (aAb) (1)
- autoimmune antibodies (1)
- autoimmune nodopathy (1)
- behavioral disorders (1)
- binding analysis (1)
- biopsies (1)
- candidate gene (1)
- cell binding assay (1)
- channel (1)
- click-chemistry (1)
- clinical neurology (1)
- complement deposition (1)
- contactin (1)
- dSTORM (1)
- domain (1)
- dominant (1)
- enzyme assays (1)
- enzyme-linked immunoassays (1)
- extracellular domain (1)
- fast decay (1)
- fear (1)
- genetic code expansion (1)
- gephyrin (1)
- glycine receptor (GlyR) (1)
- glycine receptor autoantibodies (1)
- glycine transporter 2 (1)
- glycine uptake (1)
- glycosylation (1)
- glyvine uptake (1)
- human startle disease (1)
- hyaluronic acid (1)
- inflammatory demyelinating polyradiculoneuropathy (1)
- inflammatory neuropathy (1)
- interaction partners (1)
- intracellular domain (1)
- knockout mice (1)
- ligand potencies (1)
- linalool (1)
- linalyl acetate (1)
- loop B (1)
- loss of function (1)
- mechanisms (1)
- motor proteins (1)
- mouse (1)
- mouse model (1)
- movement disorders (1)
- musk myasthenia gravis (1)
- mutations (1)
- nerve fibers (1)
- neuronal networks (1)
- neuropathy (1)
- node of ranvier (1)
- ontactin 1 (1)
- oxygenation (1)
- paranodopathy (1)
- patch clamp recording (1)
- patch-clamp (1)
- periperal nerve (1)
- posttranslational modifications (1)
- presynaptic hyperekplexia (1)
- progressive encephalitis with rigidity and myoclonus (PERM) (1)
- protein maturation (1)
- protein transport (1)
- pyridoxal phosphatase (PDXP) (1)
- receptor (1)
- rescue (1)
- side chain properties (1)
- site (1)
- spastic (1)
- spinal cord neurons (1)
- spontaneous mouse mutants (1)
- startle (1)
- startle reaction (1)
- stiff-person syndrome (SPS) (1)
- structural disruption (1)
- super-resolution microscopy (SRM) (1)
- switch (1)
- trafficking (1)
- trafficking pathways (1)
- vitamin B6 (1)
- β8-β9 loop (1)
Institute
- Institut für Klinische Neurobiologie (23)
- Neurologische Klinik und Poliklinik (9)
- Rudolf-Virchow-Zentrum (6)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (3)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Institut für Pharmakologie und Toxikologie (1)
- Institut für Pharmazie und Lebensmittelchemie (1)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (1)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (1)
Introduction
IgG4 autoantibodies against paranodal proteins are known to induce acute-onset and often severe sensorimotor autoimmune neuropathies. How autoantibodies reach their antigens at the paranode in spite of the myelin barrier is still unclear.
Methods
We performed in vitro incubation experiments with patient sera on unfixed and unpermeabilized nerve fibers and in vivo intraneural and intrathecal passive transfer of patient IgG to rats, to explore the access of IgG autoantibodies directed against neurofascin-155 and contactin-1 to the paranodes and their pathogenic effect.
Results
We found that in vitro incubation resulted in weak paranodal binding of anti-contactin-1 autoantibodies whereas anti-neurofascin-155 autoantibodies bound to the nodes more than to the paranodes. After short-term intraneural injection, no nodal or paranodal binding was detectable when using anti-neurofascin-155 antibodies. After repeated intrathecal injections, nodal more than paranodal binding could be detected in animals treated with anti-neurofascin-155, accompanied by sensorimotor neuropathy. In contrast, no paranodal binding was visible in rats intrathecally injected with anti-contactin-1 antibodies, and animals remained unaffected.
Conclusion
These data support the notion of different pathogenic mechanisms of anti-neurofascin-155 and anti-contactin-1 autoantibodies and different accessibility of paranodal and nodal structures.